128 related articles for article (PubMed ID: 8844103)
1. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
[TBL] [Abstract][Full Text] [Related]
3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
4. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
6. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML.
Thiele J; Kvasnicka HM; Zirbes TK; Baldus SE; Djuren O; Lienhard H; Lorenzen J; Leder LD; Niederle N; Fischer R
Hematopathol Mol Hematol; 1996; 10(4):201-12. PubMed ID: 9042663
[TBL] [Abstract][Full Text] [Related]
8. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
[TBL] [Abstract][Full Text] [Related]
9. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
[TBL] [Abstract][Full Text] [Related]
10. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
11. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival.
Thiele J; Hoefer M; Kvasnicka HM; Bertsch HP; Zankovich R; Fischer R
Hematol Pathol; 1993; 7(4):239-49. PubMed ID: 7906686
[TBL] [Abstract][Full Text] [Related]
12. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
14. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
Marisavljević D; Rolović Z; Mitrović D
Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
[TBL] [Abstract][Full Text] [Related]
15. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
18. [Interferon alpha--the drug of choice for patients with chronic myeloid leukemia].
Klamová H; Vítek A; Michalová K; Brezinová J; Moravcová J; Jelínek J; Cermák J
Cas Lek Cesk; 1998 Sep; 137(18):552-6. PubMed ID: 9818464
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
20. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
